🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bios Capital Management - Q4 2025 13F Filings

BI

Bios Capital Management, Lp

CIK: 0001813845
Address: Texas Fort Worth 1751 River Run Suite 400
$82.62 M
Portfolio Value
6
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 08/14/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
+$592,996

Top Sells

Q4 2025
1. In8bio
−$622,061
−$18,810.24

Asset Allocation

Stocks/ETFs
-7.07%
$82.62 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Bios Capital Management Q4 2025 Filing Summary

Bios Capital Management, Lp filed its 13F report for Q4 2025 on February 13, 2026. The portfolio totaled 82.62 M reflecting a -7.07% change from the prior quarter, spanning 6 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 1 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Bios Capital Management’s Q4 2025 Filing

Bios Capital Management submitted their Form 13F-HR for the Q4 2025 period on 02/13/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Bios Capital Management reported a managed portfolio value of 82.62 M, consisting of 9 individual positions.

This page displays the raw filing documents. To see which stocks Bios Capital Management bought or sold during Q4 2025, please visit Bios Capital Management's Portfolio Analysis page.